Malignant neoplasm of scrotum
ICD-10 C63.2 is a billable code used to indicate a diagnosis of malignant neoplasm of scrotum.
Malignant neoplasm of the scrotum is a rare form of cancer that primarily affects the male genital region. It is characterized by the uncontrolled growth of malignant cells in the scrotal tissue, which can arise from various cell types, including squamous cells, basal cells, and germ cells. The etiology of scrotal cancer is often linked to chronic irritation, exposure to carcinogenic substances, and certain genetic predispositions. Symptoms may include a palpable mass, pain, swelling, or changes in the skin of the scrotum. Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy. Staging of the cancer is crucial for determining the appropriate treatment plan and prognosis, often utilizing the TNM classification system, which assesses tumor size, lymph node involvement, and metastasis. Treatment options may include surgical excision, radiation therapy, and chemotherapy, depending on the stage and type of cancer. Additionally, considerations regarding fertility are paramount, as treatments may impact reproductive capabilities. Regular monitoring of prostate-specific antigen (PSA) levels may also be relevant in the context of male genital malignancies, although PSA is primarily associated with prostate cancer.
Comprehensive documentation of physical examination findings, imaging results, and biopsy reports.
Diagnosis and management of scrotal masses, post-operative follow-up for scrotal cancer, and fertility preservation discussions.
Urologists must ensure clear documentation of the tumor's characteristics and staging to support accurate coding.
Detailed treatment plans, including chemotherapy regimens and radiation therapy protocols.
Management of advanced scrotal cancer, coordination of care with urologists, and monitoring for recurrence.
Oncologists should document the rationale for treatment choices and any impact on fertility.
Used for unlisted procedures related to scrotal cancer treatment.
Detailed description of the procedure performed and rationale.
Urologists and oncologists should ensure clarity in documentation to support the use of unlisted codes.
Common symptoms include a palpable mass, pain, swelling, and changes in the skin of the scrotum. Patients may also experience discomfort or changes in urinary function.
